A carregar...
Structural basis for rifamycin resistance of bacterial RNA polymerase by the three most clinically important RpoB mutations found in Mycobacterium tuberculosis
Since 1967, Rifamaycin (RIF) has been used as a first line antibiotic treatment for tuberculosis (TB), and it remains the cornerstone of current short-term TB treatment. Increased occurrence of RIF-resistant (RIF(R)) TB, ~41% of which results from the RpoB S531L mutation in RNA polymerase (RNAP), ha...
Na minha lista:
| Publicado no: | Mol Microbiol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5344776/ https://ncbi.nlm.nih.gov/pubmed/28009073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/mmi.13606 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|